¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"measles immune globulin"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • albumin-globulin ratio
    ¾ËºÎ¹Î±Û·ÎºÒ¸°ºñ
  • corticosteroid-binding globulin
    ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å°áÇձ۷κҸ°
  • cortisol-binding globulin
    ÄÚÆ¼¼Ö°áÇձ۷κҸ°
  • globulin
    ±Û·ÎºÒ¸°
  • gamma globulin
    °¨¸¶±Û·ÎºÒ¸°
  • gonadal steroid-binding globulin
    »ý½Ä»ù½ºÅ×·ÎÀ̵å°áÇձ۷κҸ°
  • hyperimmune globulin
    °ú´Ù¸é¿ª±Û·ÎºÒ¸°
  • myeloma globulin
    °ñ¼öÁ¾±Û·ÎºÒ¸°
  • rheumatoid agglutinating globulin
    ·ù¸¶Æ¼½ºÀÀÁý±Û·ÎºÒ¸°
  • sex hormone-binding globulin
    ¼ºÈ£¸£¸ó°áÇձ۷κҸ°
  • acquired immune deficiency syndrome
    ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
  • circulating immune complex
    ¼øÈ¯¸é¿ªº¹ÇÕü
  • drug-induced immune complex
    ¾à¹°À¯¹ß¸é¿ªº¹ÇÕü
  • immune
    ¸é¿ª-
  • immune adherence
    ¸é¿ªºÎÂø
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • antitoxic globulin
    Ç×µ¶¼º±Û·ÎºÒ¸°
  • corticosteroid-binding globulin
    ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å°áÇձ۷κҸ°
  • cortisol-binding globulin
    ÄÚ¸£Æ¼¼Ö°áÇÕ±Û·Îºí¸°
  • globulin-coated erythrocyte
    ±Û·ÎºÒ¸°ÇǸ·ÀûÇ÷±¸
  • globulin
    ±Û·ÎºÒ¸°
  • gonadal steroid-binding globulin
    »ý½Ä»ù½ºÅ×·ÎÀ̵å°áÇձ۷κҸ°
  • hyperimmune globulin
    °ú´Ù¸é¿ª±Û·ÎºÒ¸°
  • myeloma globulin
    °ñ¼öÁ¾±Û·ÎºÒ¸°
  • rheumatoid agglutinating globulin
    ·ù¸¶Æ¼½ºÀÀÁý±Û·ÎºÒ¸°
  • sex hormone-binding globulin
    ¼ºÈ£¸£¸ó°áÇÕ±Û·Îºí¸°
  • testosterone-binding globulin
    Å×½ºÅ佺Å׷аáÇձ۷κҸ°
  • thyroxine-binding globulin
    Ƽ·Ï½Å°áÇÕ±Û·Îºí¸°
  • acquired immune deficiency
    ÈÄõ¸é¿ª°áÇÌ
  • acquired immune deficiency syndrome
    ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
  • ancillary immune system
    º¸Á¶¸é¿ª°è
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hemorrhagic measles
    ÃâÇ÷(¼º) È«¿ª.
  • AHG=£¾antihemophilic globulin
    Ç×Ç÷¿ì±Û·ÎºÒ¸°.
  • A£¯G ratio=£¾albumin globulin ratio
    A£¯G ºñ.
  • Corticosteroids binding globulin
    ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå °áÇÕ ±Û·ÎºÒ¸°
  • GBG (Gonadal steriod-binding globulin)
    »ý½Ä¼±(ßæãÖàÍ)½ºÅ×·ÎÀ̵å°áÇÕ(Ì¿ùê)±Û·ÎºÒ¸°
  • Gamma globulin
    °¨¸¶±Û·ÎºÒ¸°
  • Gamma globulin antibodies
    °¨¸¶±Û·ÎºÒ¸°Ç×ü(ù÷ô÷)
  • Gc-globulin
    Gc-±Û·ÎºÒ¸°
  • Globulin
    ±Û·ÎºÒ¸°
  • Gonadal steroids-binding globulin
    ¼º¼±(àõàÍ)½ºÅ×·ÎÀÌµå °áÇÕ(Ì¿ùê)±Û·ÎºÒ¸°
  • TBG => thyroxine binding globulin
    ŸÀ̷ϽаáÇÕ ±Û·ÎºÎ¸°
  • albumin-globulin ratio =A£¯G r.
    ¾ËºÎ¹Î ±Û·ÎºÒ¸°ºñ.
  • albumin/globulin ratio
    ¾ËºÎ¹Î/±Û·ÎºÒ¸° ºñ
  • anti-lymphocyte globulin
    ¸²ÇÁ±¸ Çױ۷κҸ°
  • antihuman globulin
    Ç×ÀÎ(ù÷ìÑ)±Û·ÎºÒ¸°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • german measles
    dzÁø(ù¦òÖ)
  • german measles =rubella
    dzÁø(ù¦òÖ).
  • hemorrhagic measles
    ÃâÇ÷(¼º) È«¿ª.
  • measles
    È«¿ª
  • measles
    È«¿ª(ûõæ¹).
  • measles
    È«¿ª(ûõæ¹)
  • measles maculopathy
    È«¿ªÈ²¹Ýº´Áõ
  • measles virus
    È«¿ª(ûõæ¹)¹ÙÀÌ·¯½º.
  • measles virus
    È«¿ª ¹ÙÀÌ·¯½º
  • measles virus antibody
    È«¿ª¹ÙÀÌ·¯½ºÇ×ü
  • measles, German
    dzÁø
  • rubella =German measles
    dzÁø(ù¦òÖ).
  • rubella =german measles
    dzÁø(ù¦òÖ).
  • albumin-globulin ratio =A£¯G r.
    ¾ËºÎ¹Î ±Û·ÎºÒ¸°ºñ.
  • albumin/globulin ratio
    ¾ËºÎ¹Î/±Û·ÎºÒ¸° ºñ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • thyroxine-binding globulin
    ŸÀ̷ϽŰáÇÕ(Ì¿ùê) ±Û·ÎºÒ¸°
  • hemolytic immune body
    ¿ëÇ÷ ¸é¿ªÃ¼(éÁúìØóæ¹ô÷)
  • immune adherence
    ¸é¿ª ºÎÂø(Øóæ¹Ý¾ó·)
  • immune adsorbent
    ¸é¿ª ÈíÂøÁ¦(Øóæ¹ýåó·ð¥)
  • immune antibody
    ¸é¿ª Ç×ü(Øóæ¹ù÷ô÷)
  • immune clearance
    ¸é¿ª ûÁ¤(Øóæ¹ôèïä)
  • immune competent cell
    ¸é¿ª Àû°Ý ¼¼Æ÷(Øóæ¹îêÌ«á¬øà)
  • immune complex
    ¸é¿ª º¹ÇÕü(Øóæ¹ÜÜùêô÷)
  • immune conglutination
    ¸é¿ª À¯Âø ¹ÝÀÀ(Øóæ¹ë¨ó·Úãëë)
  • immune conglutinin
    ¸é¿ª(Øóæ¹)ÄÜ±Û·çÆ¼´Ñ
  • immune cytolysis
    ¸é¿ª ¼¼Æ÷¿ëÇØ(Øóæ¹á¬øàéÁú°)
  • immune deficincy disease
    ¸é¿ª °áÇÌ Áúȯ(Øóæ¹ÌÀù¹òðü´)
  • immune elimination
    ¸é¿ª À̹° Á¦°Å(Øóæ¹ì¶Úªð¶ËÛ)
  • immune lysis
    ¸é¿ª ¿ëÇØ(Øóæ¹éÁú°)
  • immune opsonin
    ¸é¿ª(Øóæ¹) ¿É¼Ò´Ñ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ISG Immune Serum Globulin
RIG Rabies Immune Globulin
TIG: (human) Tetanus Immune(Immuno-) Globulin ÆÄ»ódz Àΰ£ ¸é¿ª ±Û·ÎºÒ¸°
HTIG human tetanus immune globulin
IGIV immune globulin intravenous
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RIG Rabies immune globulin
RhIG Rh immune globulin
MMR MEASLES: mumps-rubella
MV Measles virus
MMR Measles, mumps and rubella
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acquired immune deficiency syndrome
    ÈÄõ¼º ¸é¿ª °áÇÌ ÁõÈıº
    1. ÇöÀúÇÑ ¸é¿ª °áÇ̰ú ÇÔ²² ±âȸ°¨¿°, ¼Ó¹ß¼º ¾Ï ¹× ½Å°æ°è Áõ¼¼°¡ µ¿¹Ý. ¹ÙÀÌ·¯½º ÀÚü¿¡ ÀÇÇÑ º´º¯°ú ¸é¿ª´É·Â ÀúÇÏ¿¡ µû¸¥ ±âȸ °¨¿° µîÀÇ ÀÌÂ÷Àû º´º¯ÀÇ µÎ °¡Áö·Î ´ëº°. HIV¿¡ ÀÇÇØ ¹ß»ýµÇ´Â ÁúȯÀ¸·Î ½Å°æ°è°¡ Áß¿ä Ç¥ÀûÁß Çϳª. ¹ÙÀÌ·¯½º¿¡ °¨¿°µÈ »ç¶÷ÀÇ 40% Á¤µµ°¡ Áúº´ÀÌ ¹ß»ý. ¹ÙÀÌ·¯½ºÀÇ Á÷Á¢ÀûÀÎ ¿µÇâ¿¡ ÀÌÇÑ º´º¯À¸·Î´Â ¸²ÇÁ±¸¼º ¼ö¸·¿°°ú HIV ³ú¿° µîÀÌ ÀÖÀ½. 2. ÈÄõ¼º ¸é¿ª°áÇÌÁõ. Àΰ£ ¸é¿ª°áÇÌ ¹ÙÀÌ·¯½º
  • acquired immune deficiency syndrome
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • drug-induced immune complex
    ¾àÁ¦ À¯¹ß¼º ¸é¿ª º¹ÇÕü
  • ensitization 1. administration of antigen to induce a primary immune response; priming; immunization. 2. exposure to allergen that results in the development of hypersensitivity. 3. the coating of erythrocytes with antibody so that they are subject to lys
    ³»¹ø
    ƯÈ÷ ¾È°Ë ¿¬ÀÇ.
  • immune
    ¸é¿ª
    1. ü¾× Ç×üÀÇ »ý»ê, ¼¼Æ÷¼º ¸é¿ªÀÇ ¼º¸³, ¶Ç´Â ±× ¾çÀÚ, ȤÀº ¹ÙÀÌ·¯½º °¨¿°¿¡¼­ÀÇ ÀÎÅÍÆä·Ð Ȱ¼º°ú °°ÀÌ ´Ù¸¥ ±âÁ¤ÀÇ °á°ú µî¿¡ ÀÇÇÏ¿© Áúȯ¿¡ ´ëÇÑ ÀúÇ×·ÂÀÌ ³ô¾ÆÁø »óÅÂ. 2. Ç׿ø °ø°Ý¿¡ ÀÇÇÑ Ã¼¾×¼º Ç×ü ¶Ç´Â ¼¼Æ÷¼º ¸é¿ª, ¶Ç´Â ±× ¾çÀÚÀÇ ¼º¸³. 3. ¸é¿ªÇ÷û ±Û·ÎºÒ¸°°ú °°ÀÌ Ç׿ø °ø°Ý¿¡ ´ëÀÀÇÏ¿© »ý»êµÈ °Í. 4. ¸é¿ªÀÌ µÈ °³Ã¼. 5. ƯÀÌÀû ¶Ç´Â ºñƯÀÌÀû ±âÀüÀ» ÅëÇØ °¨¿°¼º Áúȯ¿¡ ´ëÇ×ÇÏ´Â °Í.
  • immune amnesia syndrome
    ¸é¿ª ±â¾ï »ó½Ç ÁõÈıº
  • immune complex
    ¸é¿ª º¹ÇÕü
    Ç׿ø°ú Ç×üÀÇ Æ¯Á¤ °áÇÕ¹°. ¹ÙÀÌ·¯½º³ª ¼¼±Õ µî À̹°ÀÇ Ä¨ÀÔ¿¡ ´ëÇØ¼­ »ýü°¡ »ý»êÇÑ Ç×ü´Â À̹°ÀÎ Ç׿ø°ú °áÇÕÇÏ¿© ¸é¿ª º¹ÇÕü¸¦ ¸¸µç´Ù. À̴ Ž½Ä ¼¼Æ÷³ª º¸Ã¼¸¦ Ȱ¼ºÈ­ÇÏ¿© À̹°ÀÌ ¹«ÇØÇÑ °ÍÀ¸·Î ºÐÇØÇÏ´Â °ÍÀ» µµ¿Í »ýü ¹æ¾î¿¡ µµ¿òÀ» ÁØ´Ù. Á¶Á÷ Àå¾ÖÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ¸é¿ª º¹ÇÕ¼º ÁúȯÀ» ÀÏÀ¸Å°±âµµ ÇÑ´Ù.
  • immune complex-mediated
    ¸é¿ª º¹ÇÕü ¸Å°³¼º
  • immune deficiency disease
    ¸é¿ª °áÇÌ Áúȯ, ¸é¿ª °áÇ̺´
    ¸é¿ª °èÅëÀ» ±¸¼ºÇÏ´Â ¿ä¼ÒÀÇ ±â´É Àå¾Ö¿¡ ÀÇÇÏ¿© ÃÊ·¡µÇ´Â Áúȯ ±º.
  • immune electron microscopy
    ¸é¿ª ÀüÀÚÇö¹Ì°æ¹ý
  • immune mechanism
    ¸é¿ª ±âÀü
  • immune reaction
    ¸é¿ª ¹ÝÀÀ
    Ç׿ø°ú Ç×ü »çÀÌÀÇ ¹ÝÀÀ.
  • immune response
    ¸é¿ª ¹ÝÀÀ
  • immune serum
    ¸é¿ª Ç÷û
    ¾î¶² Ç׿ø¿¡ ´ëÇÑ Æ¯ÀÌÀû Ç×ü¸¦ ÇÔÀ¯Çϰí ÀÖ´Â Ç÷û. Ç×Ç÷ûÀ̶ó°íµµ ÇÑ´Ù. Áúº´ Ä¡·á
  • immune system
    ¸é¿ª °èÅë, ¸é¿ª°è
    °¨¿°À̳ª Áúº´À¸·ÎºÎÅÍ ½Åü¸¦ ¹æ¾îÇϴµ¥ °ü¿©ÇÏ´Â ¿©·¯ ¼¼Æ÷¿Í Àå±â Áý´Ü.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
german measles immunization The standard MMR vaccine is given to prevent measles, mumps and rubella (German measles). The MMR vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination should be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or MMR vaccination prior to entrance. Most children should receive MMR vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the MMR vaccine. Pregnant women should wait until after delivery before being immunised with MMR. People with HIV or AIDS should normally receive MMR vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination.
(12 Dec 1998)
German measles virus The type (and only) species of rubivirus causing acute infection in humans, primarily children and young adults. Humans are the only natural host. A live, attenuated vaccine is available for prophylaxis.
(12 Dec 1998)
measles <virology> An acute infectious disease caused by the measles virus, a Morbillivirus in the paramyxovirus family.
Early symptoms include a low-grade fever, dry cough, pinkeye and cold symptoms. Later symptoms include tiny, white spots lining the inside of the cheeks (Koplik spots) and a red rash which starts on the face and spreads.
Synonym: rubeola.
(27 Sep 1997)
measles convalescent serum Obtained from the blood of a healthy person who has survived an attack of measles.
Synonym: measles convalescent serum.
(05 Mar 2000)
measles immunization The standard MMR vaccine is given to prevent measles, mumps and rubella (german measles). The mmr vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination should be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or mmr vaccination prior to entrance. Most children should receive mmr vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the mmr vaccine. Pregnant women should wait until after delivery before being immunised with mmr. People with HIV or aids should normally receive mmr vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination.
(12 Dec 1998)
measles immunoglobulin measles immune globulin (human)
measles, mumps and rubella vaccine A combination of live attenuated measles, mumps, and rubella viruses in an aqueous suspension; used for immunization against the respective diseases.
(05 Mar 2000)
measles vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunised with live measles vaccine and have no serum antibodies against measles. Children are usually immunised with measles-mumps-rubella combination vaccine.
(12 Dec 1998)
measles virus <virology> Paramyxovirus that causes the childhood disease measles and is responsible for subacute sclerosing panencephalitis.
(18 Nov 1997)
measles virus vaccine Vaccine containing live, attenuated strains of measles virus prepared in chick embryo cell culture.
See: measles, mumps, and rubella vaccine.
(05 Mar 2000)
haemorrhagic measles <virology> Haemorrhagic measles is a severe type of measles where the little bumps are darkly coloured because blood has escaped into the skin.
(09 Oct 1997)
immunization, german measles See Immunization, MMR.
(12 Dec 1998)
immunization, measles See Immunization, MMR.
(12 Dec 1998)
three-day measles <disease, virology> An acute, usually benign, infectious disease caused by a togavirus and most often affecting children and nonimmune young adults, in which the virus enters the respiratory tract via droplet nuclei and spreads to the lymphatic system.
It is characterised by a slight cold, sore throat and fever, followed by enlargement of the postauricular, suboccipital and cervical lymph nodes and the appearances of a fine pink rash that begins on the head and spreads to become generalised.
Synonym: German measles, rubeola.
Origin: L. Rubellus = reddish, ruber = red
(17 Dec 1997)
tropical measles <infectious disease, virology> A disease of uncertain character, somewhat resembling rubella, occurring in southern China.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á